122 related articles for article (PubMed ID: 8255107)
21. Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group study.
Abshire TC; Buchanan GR; Jackson JF; Shuster JJ; Brock B; Head D; Behm F; Crist WM; Link M; Borowitz M
Leukemia; 1992 May; 6(5):357-62. PubMed ID: 1534389
[TBL] [Abstract][Full Text] [Related]
22. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
23. Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative.
Pui CH; Raimondi SC; Hancock ML; Rivera GK; Ribeiro RC; Mahmoud HH; Sandlund JT; Crist WM; Behm FG
J Clin Oncol; 1994 Dec; 12(12):2601-6. PubMed ID: 7989935
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic value of pre-B immunophenotype in early treatment response among acute pediatric lymphoblast leukemia patients].
Correa-González LC; Mandeville PB; Manrique-Dueñas J; Alejo-González F; Salazar-Martínez A; de Pérez-Ramírez OJ; Hernández-Sierra JF
Gac Med Mex; 2005; 141(6):477-82. PubMed ID: 16381501
[TBL] [Abstract][Full Text] [Related]
26. [Immunophenotyping of acute lymphoblastic leukemia in Mexican children].
Paredes-Aguilera R; Romero-Guzmán L; López-Santiago N; Bravo-Lindoro A; Correa-González C; Joly-Linero R; Nieto-Martínez S; del Campo-Martínez A
Sangre (Barc); 1999 Jun; 44(3):188-94. PubMed ID: 10481579
[TBL] [Abstract][Full Text] [Related]
27. Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia.
Morishita N; Tsukahara H; Chayama K; Ishida T; Washio K; Miyamura T; Yamashita N; Oda M; Morishima T
Pediatr Blood Cancer; 2012 Jul; 59(1):83-9. PubMed ID: 22183914
[TBL] [Abstract][Full Text] [Related]
28. A comparative analysis of cytoplasmic mu (C mu) expression in acute lymphoblastic leukemia by molecular and immunologic techniques. Identification of leukemia cases expressing C mu mRNA transcripts in the absence of detectable C mu proteins.
Little JV; Foucar K; Duncan MH; Crago SS; McConnell TS; Griffith B; Chen IM; Vogler LB; Willman CL
Am J Clin Pathol; 1992 Jun; 97(6):885-92. PubMed ID: 1595611
[TBL] [Abstract][Full Text] [Related]
29. Acute lymphoblastic leukemia with the (4;11) translocation: combined cytogenetic, immunological and molecular genetic analyses.
Schardt C; Ottmann OG; Hoelzer D; Ganser A
Leukemia; 1992 May; 6(5):370-4. PubMed ID: 1375695
[TBL] [Abstract][Full Text] [Related]
30. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression.
Cascavilla N; Musto P; D'Arena G; Ladogana S; Matera R; Carotenuto M
Haematologica; 1997; 82(1):31-7. PubMed ID: 9107079
[TBL] [Abstract][Full Text] [Related]
31. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
Wiersma SR; Ortega J; Sobel E; Weinberg KI
N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
33. CD10 AND CD34 expression in childhood acute lymphoblastic leukemia in Morocco: clinical relevance and outcome.
Dakka N; Bellaoui H; Bouzid N; Khattab M; Bakri Y; Benjouad A
Pediatr Hematol Oncol; 2009 Jun; 26(4):216-31. PubMed ID: 19437324
[TBL] [Abstract][Full Text] [Related]
34. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
35. Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia.
Liang DC; Yang CP; Lin DT; Hung IJ; Lin KH; Chen JS; Hsiao CC; Chang TT; Peng CT; Lin MT; Chang TK; Jaing TH; Liu HC; Wang LY; Yeh TC; Jou ST; Lu MY; Cheng CN; Sheen JM; Chiou SS; Wu KH; Hung GY; Chen RL; Chen SH; Cheng SN; Chang YH; Chen BW; Ho WL; Wang JL; Lin ST; Hsieh YL; Wang SC; Chang HH; Yang YL; Huang FL; Chang CY; Chang WH; Lin KS
Leukemia; 2010 Feb; 24(2):397-405. PubMed ID: 20016538
[TBL] [Abstract][Full Text] [Related]
36. Precursor B lymphoblastic leukemia with surface light chain immunoglobulin restriction: a report of 15 patients.
Kansal R; Deeb G; Barcos M; Wetzler M; Brecher ML; Block AW; Stewart CC
Am J Clin Pathol; 2004 Apr; 121(4):512-25. PubMed ID: 15080303
[TBL] [Abstract][Full Text] [Related]
37. [Immunophenotype. Clinical and laboratory features of acute lymphoblastic leukemia in Chile. Study of 500 children and 131 adults].
Cabrera ME; Labra S; Ugarte S; Matutes E; Greaves MF
Rev Med Chil; 1996 Mar; 124(3):293-9. PubMed ID: 9008940
[TBL] [Abstract][Full Text] [Related]
38. Use of clinical and laboratory features to define prognostic subgroups in B-precursor acute lymphoblastic leukemia: experience of the Pediatric Oncology Group.
Borowitz MJ; Carroll AJ; Shuster JJ; Look AT; Behm FG; Pullen DJ; Land VJ; Steuber P; Crist WM
Recent Results Cancer Res; 1993; 131():257-67. PubMed ID: 8210645
[No Abstract] [Full Text] [Related]
39. Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
Shuster JJ; Wacker P; Pullen J; Humbert J; Land VJ; Mahoney DH; Lauer S; Look AT; Borowitz MJ; Carroll AJ; Camitta B
J Clin Oncol; 1998 Aug; 16(8):2854-63. PubMed ID: 9704739
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study.
Borowitz MJ; Shuster JJ; Civin CI; Carroll AJ; Look AT; Behm FG; Land VJ; Pullen DJ; Crist WM
J Clin Oncol; 1990 Aug; 8(8):1389-98. PubMed ID: 1696310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
